Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast Off J Eur Soc Mastology. 2022;66:15–23.

Google Scholar 

Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO, Ramírez-Valdespino CA. Subtypes of breast cancer. Breast cancer internet [Internet]. Exon Publications; 2022 [cited 2023 Jul 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK583808/

Ashok G, Ramaiah S. A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery. Med Oncol. 2022;39:206.

Article  CAS  PubMed  Google Scholar 

Adamo B, Deal AM, Burrows E, Geradts J, Hamilton E, Blackwell KL, et al. Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases. Breast Cancer Res. 2011;13:R125.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dey N, De P, Leyland-Jones B. PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials. Pharmacol Ther. 2017;175:91–106.

Article  PubMed  Google Scholar 

Guo H, Zou J, Zhou L, Zhong M, He Y, Huang S, et al. NUSAP1 promotes gastric cancer tumorigenesis and progression by stabilizing the YAP1 protein. Front Oncol. 2021;10:591698.

Article  PubMed  PubMed Central  Google Scholar 

Qiu J, Xu L, Zeng X, Wu Z, Wang Y, Wang Y, et al. NUSAP1 promotes the metastasis of breast cancer cells via the AMPK/PPARγ signaling pathway. Ann Transl Med. 2021;9:1689.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M, Yang B. Prognostic value of NUSAP1 and its correlation with immune infiltrates in human breast cancer. Crit Rev Eukaryot Gene Expr. 2022;32:45–60.

Article  PubMed  Google Scholar 

Huang Y, Chen X, Wang L, Wang T, Tang X, Su X. Centromere protein F (CENPF) serves as a potential prognostic biomarker and target for human hepatocellular carcinoma. J Cancer. 2021;12:2933–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M-X, Zhang M-Y, Dong H-H, Li A-J, Teng H-F, Liu A-L, et al. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Int J Med Sci. 2021;18:494–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mi Y-J, Gao J, Xie J-D, Cao J-Y, Cui S-X, Gao H-J, et al. Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma. Dis Esophagus. 2013;26:636–43.

Article  PubMed  Google Scholar 

O’Brien SL, Fagan A, Fox EJP, Millikan RC, Culhane AC, Brennan DJ, et al. CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer. 2007;120:1434–43.

Article  PubMed  PubMed Central  Google Scholar 

Nair G, Hema Sree GNS, Saraswathy GR, Marise VLP, Krishna Murthy TP. Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor. Med Oncol. 2021;38:145.

Article  CAS  PubMed  Google Scholar 

Zhuo Y-J, Xi M, Wan Y-P, Hua W, Liu Y-L, Wan S, et al. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer. Int J Mol Med. 2015;35:966–72.

Article  CAS  PubMed  Google Scholar 

Hsu P-K, Chen H-Y, Yeh Y-C, Yen C-C, Wu Y-C, Hsu C-P, et al. TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma. J Gastroenterol. 2014;49:1231–40.

Article  CAS  PubMed  Google Scholar 

Koike Y, Yin C, Sato Y, Nagano Y, Yamamoto A, Kitajima T, et al. TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma. Oncol Lett. 2022;23:1–9.

Article  Google Scholar 

Liang B, Jia C, Huang Y, He H, Li J, Liao H, et al. TPX2 level correlates with hepatocellular carcinoma cell proliferation, apoptosis, and EMT. Dig Dis Sci. 2015;60:2360–72.

Article  CAS  PubMed  Google Scholar 

Jiang Y, Liu Y, Tan X, Yu S, Luo J. TPX2 as a novel prognostic indicator and promising therapeutic target in triple-negative breast cancer. Clin Breast Cancer. 2019;19:450–5.

Article  CAS  PubMed  Google Scholar 

Chen G, Yu M, Cao J, Zhao H, Dai Y, Cong Y, et al. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Bioengineered. 2021;12:5149–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Li J, Xu L, Wei W, Cheng A, Zhang L, et al. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1. J Exp Clin Cancer Res. 2022;41:149.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu F, Shi X, Zhang R, Tian Y, Wang X, Wei C, et al. Regulation of proliferation and cell cycle by protein regulator of cytokinesis 1 in oral squamous cell carcinoma. Cell Death Dis. 2018;9:1–12.

Article  Google Scholar 

Yun HJ, Cho Y-H, Moon Y, Park YW, Yoon H-K, Kim Y-J, et al. Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2. Exp Mol Med. 2008;40:345–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006;38:1043–8.

Article  CAS  PubMed  Google Scholar 

Chuang HY, Ou YH. Abstract 4068: overexpression of anillin in colorectal cancer promotes the cell proliferation, cell mobility and cell invasion. Cancer Res. 2014;74:4068.

Article  Google Scholar 

Jia H, Yu F, Li B, Gao Z. Actin-binding protein anillin promotes the progression of gastric cancer in vitro and in mice. J Clin Lab Anal. 2020;35:e23635.

Article  PubMed  PubMed Central  Google Scholar 

Wang D, Naydenov NG, Dozmorov MG, Koblinski JE, Ivanov AI. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation. Breast Cancer Res. 2020;22:3.

Article  PubMed  PubMed Central  Google Scholar 

Magnusson K, Gremel G, Rydén L, Pontén V, Uhlén M, Dimberg A, et al. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer. BMC Cancer. 2016;16:904.

Article  PubMed  PubMed Central  Google Scholar 

Zhang L-H, Wang D, Li Z, Wang G, Chen D-B, Cheng Q, et al. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2021;20:337–44.

Article  CAS  PubMed  Google Scholar 

Koyuncu D, Sharma U, Goka ET, Lippman ME. Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival. Breast Cancer Res Treat. 2021;185:331–41.

Article  CAS  PubMed  Google Scholar 

Chen J, Liao Y, Fan X. Prognostic and clinicopathological value of BUB1B expression in patients with lung adenocarcinoma: a meta-analysis. Expert Rev Anticancer Ther. 2021;21:795–803.

Article  CAS  PubMed  Google Scholar 

Tian J-H, Mu L-J, Wang M-Y, Zeng J, Long Q-Z, Guan B, et al. BUB1B promotes proliferation of prostate cancer via transcriptional regulation of MELK. Anti-Cancer Agents Med Chem- Anti-Cancer Agents. 2020;20:1140–6.

Article  CAS  Google Scholar 

Al-Khafaji ASK, Marcus MW, Davies MPA, Risk JM, Shaw RJ, Field JK, et al. AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncol Lett. 2017;13:4463.

Article